Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajay Vora

Showing results (81-90 of 166) with videos related to

Pageof 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2022
Time to Cure for Childhood and Young Adult Acute Lymphoblastic Leukemia Is Independent of Early Risk Factors: Long-Term Follow-Up of the UKALL2003 TrialAnthony V Moorman, Grace Antony, Rachel Wade, et al.
Leukemia|June 29, 2021
Prognostic value of Oncogenetic mutations in pediatric T Acute Lymphoblastic Leukemia: a comparison of UKALL2003 and FRALLE2000T protocolsMary M Taj, Anthony V Moorman, Lina Hamadeh, et al.
Blood|June 25, 2014
A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemiaAnthony V Moorman, Amir Enshaei, Claire Schwab, et al.
British Journal of Haematology|February 16, 2019
The incidence of invasive fungal infections in children, adolescents and young adults with acute lymphoblastic leukaemia/lymphoma treated with the UKALL2011 protocol: a multicentre retrospective studyMaeve A O'Reilly, Dinisha Govender, Amy A Kirkwood, et al.
Blood|February 12, 2020
Blinatumomab for infant acute lymphoblastic leukemiaKatherine Clesham, Vasudha Rao, Jack Bartram, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 4, 2017
Use of Minimal Residual Disease Assessment to Redefine Induction Failure in Pediatric Acute Lymphoblastic LeukemiaDavid O'Connor, Anthony V Moorman, Rachel Wade, et al.
British Journal of Haematology|October 22, 2021
Genetic characterisation of childhood B-other-acute lymphoblastic leukaemia in UK patients by fluorescence in situ hybridisation and Multiplex Ligation-dependent Probe AmplificationClaire J Schwab, Daniel Murdy, Ellie Butler, et al.
Haematologica|March 10, 2018
Prognostic impact of the absence of biallelic deletion at the <i>TRG</i> locus for pediatric patients with T-cell acute lymphoblastic leukemia treated on the Medical Research Council UK Acute Lymphoblastic Leukemia 2003 trialNadine Farah, Amy A Kirkwood, Sunniyat Rahman, et al.
Leukemia|June 6, 2024
ETV6::RUNX1 Acute Lymphoblastic Leukemia: how much therapy is needed for cure?Anna Østergaard, Marta Fiocco, Hester de Groot-Kruseman, et al.
British Journal of Haematology|March 29, 2022
Activity and toxicity of intramuscular 1000 iu/m<sup>2</sup> polyethylene glycol-E. coli L-asparaginase in the UKALL 2003 and UKALL 2011 clinical trialsJasmeet Sidhu, Ashish Narayan Masurekar, Manash Pratim Gogoi, et al.
Pageof 17

Showing results (81-90 of 166) with videos related to

Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2022
Time to Cure for Childhood and Young Adult Acute Lymphoblastic Leukemia Is Independent of Early Risk Factors: Long-Term Follow-Up of the UKALL2003 TrialAnthony V Moorman, Grace Antony, Rachel Wade, et al.
Leukemia|June 29, 2021
Prognostic value of Oncogenetic mutations in pediatric T Acute Lymphoblastic Leukemia: a comparison of UKALL2003 and FRALLE2000T protocolsMary M Taj, Anthony V Moorman, Lina Hamadeh, et al.
Blood|June 25, 2014
A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemiaAnthony V Moorman, Amir Enshaei, Claire Schwab, et al.
British Journal of Haematology|February 16, 2019
The incidence of invasive fungal infections in children, adolescents and young adults with acute lymphoblastic leukaemia/lymphoma treated with the UKALL2011 protocol: a multicentre retrospective studyMaeve A O'Reilly, Dinisha Govender, Amy A Kirkwood, et al.
Blood|February 12, 2020
Blinatumomab for infant acute lymphoblastic leukemiaKatherine Clesham, Vasudha Rao, Jack Bartram, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 4, 2017
Use of Minimal Residual Disease Assessment to Redefine Induction Failure in Pediatric Acute Lymphoblastic LeukemiaDavid O'Connor, Anthony V Moorman, Rachel Wade, et al.
British Journal of Haematology|October 22, 2021
Genetic characterisation of childhood B-other-acute lymphoblastic leukaemia in UK patients by fluorescence in situ hybridisation and Multiplex Ligation-dependent Probe AmplificationClaire J Schwab, Daniel Murdy, Ellie Butler, et al.
Haematologica|March 10, 2018
Prognostic impact of the absence of biallelic deletion at the <i>TRG</i> locus for pediatric patients with T-cell acute lymphoblastic leukemia treated on the Medical Research Council UK Acute Lymphoblastic Leukemia 2003 trialNadine Farah, Amy A Kirkwood, Sunniyat Rahman, et al.
Leukemia|June 6, 2024
ETV6::RUNX1 Acute Lymphoblastic Leukemia: how much therapy is needed for cure?Anna Østergaard, Marta Fiocco, Hester de Groot-Kruseman, et al.
British Journal of Haematology|March 29, 2022
Activity and toxicity of intramuscular 1000 iu/m<sup>2</sup> polyethylene glycol-E. coli L-asparaginase in the UKALL 2003 and UKALL 2011 clinical trialsJasmeet Sidhu, Ashish Narayan Masurekar, Manash Pratim Gogoi, et al.
Pageof 17